Published in Trop Med Int Health on December 01, 2007
Longitudinal immune responses and gene expression profiles in type 1 leprosy reactions. J Clin Immunol (2013) 1.02
Specific IgG antibody responses may be used to monitor leprosy treatment efficacy and as recurrence prognostic markers. Eur J Clin Microbiol Infect Dis (2011) 0.87
Analysis of antibody and cytokine markers for leprosy nerve damage and reactions in the INFIR cohort in India. PLoS Negl Trop Dis (2011) 0.84
Can baseline ML Flow test results predict leprosy reactions? An investigation in a cohort of patients enrolled in the uniform multidrug therapy clinical trial for leprosy patients in Brazil. Infect Dis Poverty (2016) 0.77
Serum levels of neopterin during antimicrobial treatment for Mycobacterium ulcerans infection. Am J Trop Med Hyg (2013) 0.76
Serial measurement of the circulating levels of tumour necrosis factor and its soluble receptors 1 and 2 for monitoring leprosy patients during multidrug treatment. Mem Inst Oswaldo Cruz (2013) 0.75
Complex Type 2 Reactions in Three Patients with Hansen's Disease from a Southern United States Clinic. Am J Trop Med Hyg (2015) 0.75
A Systematic Review of Immunological Studies of Erythema Nodosum Leprosum. Front Immunol (2017) 0.75
Leprosy reactions: The predictive value of Mycobacterium leprae-specific serology evaluated in a Brazilian cohort of leprosy patients (U-MDT/CT-BR). PLoS Negl Trop Dis (2017) 0.75
Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation (1994) 6.03
Cloning of Mycobacterium bovis BCG DNA and expression of antigens in Escherichia coli. Infect Immun (1985) 4.00
The economic burden of lymphatic filariasis in India. Parasitol Today (2000) 3.15
Expression pattern of miR-146a, an inflammation-associated microRNA, in experimental and human temporal lobe epilepsy. Eur J Neurosci (2010) 2.40
c-mos proto-oncogene RNA transcripts in mouse tissues: structural features, developmental regulation, and localization in specific cell types. Mol Cell Biol (1987) 2.35
Diagnostic problems with imported cases of mycetoma in The Netherlands. Mycoses (1993) 2.12
Mapping of lymphatic filariasis in India. Ann Trop Med Parasitol (2000) 2.00
Unusual association of Kikuchi's disease and dengue virus infection evolving into systemic lupus erythematosus. J Indian Med Assoc (2000) 1.96
Atherosclerotic lesions in humans. In situ immunophenotypic analysis suggesting an immune mediated response. Lab Invest (1989) 1.74
The skin immune system (SIS): distribution and immunophenotype of lymphocyte subpopulations in normal human skin. J Invest Dermatol (1987) 1.67
Adhesion molecules on the endothelium and mononuclear cells in human atherosclerotic lesions. Am J Pathol (1992) 1.66
Prospects for elimination of bancroftian filariasis by mass drug treatment in Pondicherry, India: a simulation study. J Infect Dis (2003) 1.65
Characterization of cultured tobacco cell lines resistant to ethionine, a methionine analog. Plant Physiol (1984) 1.57
Haematological and coagulation profile in acute falciparum malaria. J Assoc Physicians India (1992) 1.56
Effectiveness of community and health services-organized drug delivery strategies for elimination of lymphatic filariasis in rural areas of Tamil Nadu, India. Trop Med Int Health (2001) 1.56
DDT indoor residual spray, still an effective tool to control Anopheles fluviatilis-transmitted Plasmodium falciparum malaria in India. Trop Med Int Health (2005) 1.54
A programme to eliminate lymphatic filariasis in Tamil Nadu state, India: compliance with annual single-dose DEC mass treatment and some related operational aspects. Trop Med Int Health (2000) 1.50
Cyclosporin A treatment in reversal reaction. Trop Geogr Med (1994) 1.45
Quantifying mosquito biting patterns on humans by DNA fingerprinting of bloodmeals. Am J Trop Med Hyg (2001) 1.44
IgG4 antibodies in Egyptian patients with schistosomiasis. Int Arch Allergy Appl Immunol (1981) 1.40
Newly recognized autosomal recessive faciothoracoskeletal syndrome. Am J Med Genet (1994) 1.39
Review of the etiopathomechanism of vitiligo: a convergence theory. Exp Dermatol (1993) 1.35
Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance. Am J Pathol (1996) 1.35
Value of butyrylthiocholine assay for identification of cholinesterase variants. J Med Genet (1970) 1.34
Predominance of "memory" T cells (CD4+, CDw29+) over "naive" T cells (CD4+, CD45R+) in both normal and diseased human skin. Arch Dermatol Res (1989) 1.29
Bancroftian filariasis in Pondicherry, south India: 1. Pre-control epidemiological observations. Epidemiol Infect (1989) 1.29
Transmission of non-A non-B hepatitis to chimpanzees by factor-IX concentrates after fatal complications in patients with chronic liver disease. Lancet (1979) 1.28
EPIFIL: the development of an age-structured model for describing the transmission dynamics and control of lymphatic filariasis. Epidemiol Infect (2000) 1.27
Immunological crossreactivity of the Mycobacterium leprae CFP-10 with its homologue in Mycobacterium tuberculosis. Scand J Immunol (2004) 1.26
A campaign of "communication for behavioural impact" to improve mass drug administrations against lymphatic filariasis: structure, implementation and impact on people's knowledge and treatment coverage. Ann Trop Med Parasitol (2006) 1.26
Association of the Köbner phenomenon with disease activity and therapeutic responsiveness in vitiligo vulgaris. Arch Dermatol (1999) 1.25
Antibody activity against Mycobacterium leprae antigen 7 during the first year of DDS treatment in lepromatous (BL-LL) leprosy. Lepr Rev (1978) 1.24
Temporal trends in incidence of Type 1 diabetes between 1986 and 2006 in Brazil. J Endocrinol Invest (2009) 1.23
A geostatistical analysis of the geographic distribution of lymphatic filariasis prevalence in southern India. Am J Trop Med Hyg (2002) 1.23
Subcellular basis of cardiac contractile failure. J Mol Cell Cardiol (1978) 1.21
Presence or absence of melanocytes in vitiligo lesions: an immunohistochemical investigation. J Invest Dermatol (1993) 1.19
Estimation of age-specific rates of acquisition and loss of Wuchereria bancrofti infection. Trans R Soc Trop Med Hyg (1990) 1.18
Treatment costs and loss of work time to individuals with chronic lymphatic filariasis in rural communities in south India. Trop Med Int Health (1999) 1.17
Situation analysis in a large urban area of India, prior to launching a programme of mass drug administrations to eliminate lymphatic filariasis. Ann Trop Med Parasitol (2005) 1.17
Digital monitoring of sleep-disordered breathing using snoring sound and arterial oxygen saturation. Am Rev Respir Dis (1993) 1.16
Hansen's disease in a general hospital: uncommon presentations and delay in diagnosis. J Eur Acad Dermatol Venereol (2008) 1.16
Multiple origins of the mtDNA 9-bp deletion in populations of South India. Am J Phys Anthropol (1999) 1.16
Subcellular distribution of monoclonal antibody defined epitopes on immunodominant Mycobacterium tuberculosis proteins in the 30-kDa region: identification and localization of 29/33-kDa doublet proteins on mycobacterial cell wall. Scand J Immunol (1991) 1.15
Functional impairment caused by lymphatic filariasis in rural areas of south India. Trop Med Int Health (1997) 1.14
Successful therapy of lethal murine visceral leishmaniasis with cystatin involves up-regulation of nitric oxide and a favorable T cell response. J Immunol (2001) 1.13
T-cell receptor gamma delta bearing cells in normal human skin. J Invest Dermatol (1990) 1.13
The impact of six rounds of single-dose mass administration of diethylcarbamazine or ivermectin on the transmission of Wuchereria bancrofti by Culex quinquefasciatus and its implications for lymphatic filariasis elimination programmes. Trop Med Int Health (2003) 1.11
Multiple immunoenzyme staining techniques. Use of fluoresceinated, biotinylated and unlabelled monoclonal antibodies. J Immunol Methods (1989) 1.10
Diminished ouabain-sensitive, sodium-potassium ATPase activity in sciatic nerves of rats with streptozotocin-induced diabetes. Exp Neurol (1976) 1.10
Two patients coinfected with Mycobacterium leprae and human immunodeficiency virus type 1 and naive for antiretroviral therapy who exhibited type 1 leprosy reactions mimicking the immune reconstitution inflammatory syndrome. J Clin Microbiol (2006) 1.10
The mosquito problem and type and costs of personal protection measures used in rural and urban communities in Pondicherry region, South India. Acta Trop (2003) 1.10
Estimation of the fecund life span of Wuchereria bancrofti in an endemic area. Trans R Soc Trop Med Hyg (1996) 1.09
Myocardial and haemodynamic effects of phentolamine. Br J Pharmacol (1971) 1.08
A novel, antigen-presenting function of melanocytes and its possible relationship to hypopigmentary disorders. J Immunol (1993) 1.08
Bancroftian filariasis in Pondicherry, south India: 2. Epidemiological evaluation of the effect of vector control. Epidemiol Infect (1989) 1.07
Heterogeneity of monoclonal antibody-reactive epitopes on mycobacterial 30-kilodalton-region proteins and the secreted antigen 85 complex and demonstration of antigen 85B on the Mycobacterium leprae cell wall surface. Infect Immun (1992) 1.06
Altered expression of interferon-gamma and interleukin-4 in inflammatory bowel disease. Inflamm Bowel Dis (1998) 1.06
Prostaglandins and heart disease. Can J Cardiol (1985) 1.05
Isolation of a laminin-binding protein from the protozoan parasite Leishmania donovani that may mediate cell adhesion. Biochem J (1999) 1.04
Macrophage differentiation in atherosclerosis. An in situ immunohistochemical analysis in humans. Am J Pathol (1992) 1.04
The relationship between microfilarial load in the human host and uptake and development of Wuchereria bancrofti microfilariae by Culex quinquefasciatus: a study under natural conditions. Parasitology (1998) 1.04
Diversity and divergence among the tribal populations of India. Ann Hum Genet (2005) 1.04
The dynamics of Wuchereria bancrofti infection: a model-based analysis of longitudinal data from Pondicherry, India. Parasitology (2004) 1.03
Transcriptional targeting of herpes simplex virus for cell-specific replication. J Virol (1997) 1.03
Control of malaria and filariasis vectors in South India. Parasitol Today (1987) 1.03
The LYMFASIM simulation program for modeling lymphatic filariasis and its control. Methods Inf Med (1998) 1.03
Extraosseous Ewing's sarcoma of the kidney. Urol Int (2002) 1.02
Reversal reaction in borderline leprosy is associated with a polarized shift to type 1-like Mycobacterium leprae T cell reactivity in lesional skin: a follow-up study. J Immunol (1997) 1.02
Larvicidal & synergestic activity of plant extracts for mosquito control. Indian J Med Res (1985) 1.02
A structured course teaching junior doctors invasive medical procedures results in sustained improvements in self-reported confidence. Clin Med (2010) 1.02
Epifil: a dynamic model of infection and disease in lymphatic filariasis. Am J Trop Med Hyg (1998) 1.02
Skin-homing T lymphocytes: detection of cutaneous lymphocyte-associated antigen (CLA) by HECA-452 in normal human skin. Arch Dermatol Res (1993) 1.00
Generation of a human melanocyte cell line by introduction of HPV16 E6 and E7 genes. In Vitro Cell Dev Biol Anim (1997) 1.00
Costimulatory molecules in human atherosclerotic plaques: an indication of antigen specific T lymphocyte activation. Atherosclerosis (1997) 1.00
Parasitological aspects of malaria persistence in Koraput district Orissa, India. Indian J Med Res (1990) 0.99
Hepatocyte growth factor induces proliferation and morphogenesis in nonparenchymal epithelial liver cells. Hepatology (1993) 0.99
Cost of mass annual single dose diethylcarbamazine distribution for the large scale control of lymphatic filariasis. Indian J Med Res (2000) 0.98
Pharmacological actions of Shilajit. Indian J Exp Biol (1988) 0.98
Microlevel epidemiological variations in malaria & its implications on control strategy. Indian J Med Res (1991) 0.97
Diethylcarbamazine (DEC)-medicated salt for community-based control of lymphatic filariasis. Cochrane Database Syst Rev (2007) 0.97
The effect of six rounds of single dose mass treatment with diethylcarbamazine or ivermectin on Wuchereria bancrofti infection and its implications for lymphatic filariasis elimination. Trop Med Int Health (2002) 0.97
Evidence of a laminin binding protein on the surface of Leishmania donovani. Biochem Biophys Res Commun (1996) 0.96
Prolonged persistence of residual Wuchereria bancrofti infection after cessation of diethylcarbamazine-fortified salt programme. Trop Med Int Health (2009) 0.96
Pattern of community compliance with spaced, single-dose, mass administrations of diethylcarbamazine or ivermectin, for the elimination of lymphatic filariasis from rural areas of southern India. Ann Trop Med Parasitol (2005) 0.96
Phagocytosis by normal human melanocytes in vitro. Exp Cell Res (1993) 0.95
Localization of alpha-fetoprotein in human and rat fetal livers. An immunohistochemical method using horseradish peroxidase. J Histochem Cytochem (1974) 0.95
Protection from experimental colitis by theaflavin-3,3'-digallate correlates with inhibition of IKK and NF-kappaB activation. Br J Pharmacol (2006) 0.95
Operational feasibility of lot quality assurance sampling (LQAS) as a tool in routine process monitoring of filariasis control programmes. Trop Med Int Health (2006) 0.94
Type 1- and type 2-like lesional skin-derived Mycobacterium leprae-responsive T cell clones are characterized by coexpression of IFN-gamma/TNF-alpha and IL-4/IL-5/IL-13, respectively. J Immunol (1998) 0.94
Disappearing bone disease: a case report. Singapore Med J (1994) 0.94
Oxytocic activity of a pure phenolic glycoside (P2) from Saraca indica Linn (Ashoka): a short communication. Indian J Med Res (1970) 0.94
Endothelial cell marker PAL-E reactivity in brain tumor, developing brain, and brain disease. Cancer (1993) 0.94
Thalidomide treatment of subacute cutaneous lupus erythematosus. Br J Dermatol (1982) 0.93
PIG3V, an immortalized human vitiligo melanocyte cell line, expresses dilated endoplasmic reticulum. In Vitro Cell Dev Biol Anim (2000) 0.93
Effect of annual mass administration of diethylcarbamazine and albendazole on bancroftian filariasis in five villages in south India. Trans R Soc Trop Med Hyg (2011) 0.93
Increased expression of adhesion receptors in both lesional and non-lesional psoriatic skin. Arch Dermatol Res (1994) 0.93
Potential of doxorubicin as an antileishmanial agent. J Parasitol (1992) 0.93
Concentration and size dependence of nano-silver dispersed water based nanofluids. J Colloid Interface Sci (2012) 0.93
Oral lesions in borderline and reactional tuberculoid leprosy. Oral Surg Oral Med Oral Pathol (1983) 0.93